
CREDIT
Debra Weinstein, Sao-Mai Nguyen-Mau, and Vincent Lee
New discovery could help prevent the formation of infectious bacterial films on hospital equipment
Bacteria are best known as free-living single cells, but in reality their lives are much more complex. To survive in harsh environments, many species of bacteria will band together and form a biofilm–a collection of cells held together by a tough web of fibers that offers protection from all manner of threats, including antibiotics. A familiar biofilm is the dental plaque that forms on teeth between brushings, but biofilms can form almost anywhere given the right conditions.
Biofilms are a huge problem in the health care industry. When disease-causing bacteria establish a biofilm on sensitive equipment, it can be impossible to sterilize the devices, raising rates of infection and necessitating expensive replacements. So researchers look for ways to break down the defenses of biofilms to prevent them from establishing a foothold.
Now, a University of Maryland-led team has found an important link in the biofilm formation process: an enzyme that shuts down the signals that bacteria use to form a biofilm. The findings, reported in the August 24, 2015 Early Online Edition of the Proceedings of the National Academy of Sciences, have far-reaching implications for the development of new treatments, and could one day help make biofilm-related complications a distant memory.
“Bacteria form biofilms because they sense a change in their environment. They do this by generating a signaling molecule, which binds to a receptor that turns on the response,” said Mona Orr, the lead author of the study and a UMD biological sciences graduate student. “But you need a way to turn off the switch–to remove the signal when it’s no longer needed. We’ve identified the enzyme that completes the process of turning off the switch.”
The well-known switch that activates biofilm formation is a signaling molecule called Cyclic-di-GMP, also known as c-di-GMP. Many species of disease-causing bacteria use c-di-GMP to signal the formation of biofilms, including Escherichia coli, Salmonella enterica and Vibrio cholerae.
But Orr and her colleagues are the first to identify the molecule that completes the process of clearing c-di-GMP from the cell, thus ending the biofilm signaling process. The molecule is an enzyme called oligoribonuclease, and much like c-di-GMP, oligoribonuclease is also common among disease-causing bacterial species.
The team studied the process in the bacteria Pseudomonas aeruginosa, a common species known to cause infections in hospital patients. But because of the genetic and physiological similarities between P. aeruginosa and other infectious species, the researchers believe that oligoribonuclease serves the same function across a wide variety of bacteria.
“You can think of this process in terms of water filling a sink. The rate of water from the faucet is just as important as the size of the drain in determining the level of water in the sink,” said Vincent Lee, a co-author of the study and an associate professor in the UMD Department of Cell Biology and Molecular Genetics and the Maryland Pathogen Research Institute. “The level of c-di-GMP in the cell is analogous to the amount of water in the sink. Because no one knew what the drain was, our findings create a complete picture of the signaling process.”
Orr, Lee and their colleagues from the UMD Department of Chemistry and Biochemistry and Michigan State University focused their work on P. aeruginosa because it is well studied and can survive under a variety of conditions, making it notoriously difficult to control. Contact lens wearers might already be familiar with P. aeruginosa, as it commonly forms infectious, green-tinted biofilms on older lenses or those that have not been cleaned properly.
The team found that oligoribonuclease is necessary for the second of a two-step process. The first, which converts c-di-GMP into an intermediate molecule called pGpG, was already known. Orr, Lee and their colleagues have now filled in the important second step in this process: oligoribonuclease breaks apart pGpG and thus completely shuts off the signaling pathway.
The result suggests that oligoribonuclease could be used to help design new antibiotics, disinfectants, and surface treatments to control biofilms. Such measures could prevent infections and preclude the need for frequent replacement of expensive hospital equipment. Because biofilms can also form on implanted medical devices, such as pacemakers and synthetic joints, effective treatments against biofilms could eliminate the need for costly and risky replacement surgeries.
Read more:Â UMD-led study identifies the off switch for biofilm formation
The Latest on: Biofilm
[google_news title=”” keyword=”biofilm” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Biofilm
- Tales From TikTok: Ladies, Wash Your Eyelash Extensions To Avoid This Crusty Conditionon July 24, 2024 at 11:27 am
The latest Tales From TikTok zeros in on a user named @It’sShoLove who highlighted the importance of washing your eyelash extensions regularly to prevent blepharitis, a common and sometimes chronic ...
- Revolution in halitosis treatment: Innovative laser technology for quick, effective resultson July 24, 2024 at 10:36 am
Halitosis, or bad breath, is a common issue affecting over a quarter of the population. Beyond personal discomfort, it can negatively impact social, work, and personal relationships.
- Xylazine wounds are a growing crisis among drug users in Philly—a nurse explains causes and treatmenton July 24, 2024 at 9:50 am
Xylazine or "tranq" wounds—characterized by deep pockets of dead tissue—have become increasingly visible in Philadelphia among people who use drugs.
- How indoor microbiomes shape our health and well-beingon July 23, 2024 at 9:19 pm
Indoor microbiomes, influenced by urbanization and building design, significantly impact human immune, neurological, and endocrine health. This research emphasizes the need for innovative approaches ...
- Here’s What Happens If You Don’t Brush Your Teeth, According to a Dentiston July 23, 2024 at 7:20 pm
What happens when you don't brush your teeth can lead to not only oral issues such as swollen, red gums, bleeding, pain when chewing, and loose teeth, but also serious complications for your heart, ...
- Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gelon July 23, 2024 at 5:57 am
This now clears the way for the introduction and extended use of Kane’s revyve™ Antimicrobial Wound Gel Spray which is expected to be filled in spray cans in a higher quantity making it ideal for ...
- Capra Biosciences Wins $7.5 million Award to Scale and Manufacture Bio-Derived Small-Molecule APIson July 19, 2024 at 4:53 pm
Biomanufacturing has the potential to make many of the chemicals we use today not only more sustainably but also where and when we need them.
- Amendment 32: E.2 Biophysics Not Solicited in ROSES-2024on July 18, 2024 at 10:06 am
Protein crystals grown in space are often more well-ordered than those grown on Earth. Theory has suggested that the chemical conditions for optimal crystal growth are different in microgravity.
- Dallas Biotech Secures $50M Series D Funding To Combat Rare Hidden Killer in Joint Replacementson July 17, 2024 at 2:11 pm
The $50 million funding will support the commercial launch of Osteal Therapeutics' pioneering combination drug/device therapy targeting biofilm infections, which are notoriously difficult to eradicate ...
- NASA researchers battle biofilm in spaceon July 11, 2024 at 1:20 am
A small group of scientists on the biofilm mitigation team at NASA's Marshall Space Center in Huntsville, Alabama, study solutions to combat fast-growing colonies of bacteria or fungi, known as ...
via Bing News